Status:
COMPLETED
Erector Spinae Plane Block in Liver Transplantation Donors
Lead Sponsor:
Medipol University
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Living donor liver transplantation has become a common treatment option for patients with end-stage liver disease. Donor hepatectomy is associated with significant postoperative pain due to inverted L...
Eligibility Criteria
Inclusion
- Donor patients scheduled for elective hepatectomy in liver transplantation surgery
- ASA I-II
- Patients who are aged between 18-65
Exclusion
- Patients who do not accept the procedure
- Skin infection at the site of Erector Spina Plan Block area
- Coagulation disorder or using anticoagulant drugs
- Known local anesthetics and opioid allergy
- Severe pulmonary and/or cardiovascular problems
- Substance addiction or known psychiatric or mental problems
- Chronic painkiller usage
- Pregnancy or lactation
Key Trial Info
Start Date :
December 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT05406388
Start Date
December 24 2020
End Date
August 1 2023
Last Update
August 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medipol University Hospital
Istanbul, Turkey (Türkiye), 34070